Pharma Foods International Co., Ltd.
PMDSF
$6.24
$0.643211.50%
OTC PK
| 01/31/2025 | 07/31/2024 | 04/30/2024 | 01/31/2024 | ||
|---|---|---|---|---|---|
| Revenue | -- | -17.14% | -14.41% | -8.35% | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | -17.14% | -14.41% | -8.35% | |
| Cost of Revenue | -- | -8.06% | -10.91% | -6.23% | |
| Gross Profit | -- | -19.33% | -15.27% | -8.87% | |
| SG&A Expenses | -- | -23.01% | -21.80% | -22.69% | |
| Depreciation & Amortization | -- | 26.52% | 29.43% | 39.52% | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | -- | -19.51% | -19.27% | -19.23% | |
| Operating Income | -- | 23.81% | 154.09% | 413.31% | |
| Income Before Tax | -- | 24.17% | 143.04% | 442.99% | |
| Income Tax Expenses | -- | 236.93% | 33.36% | -9.31% | |
| Earnings from Continuing Operations | -- | -9.00% | 233.92% | 255.15% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -201.35% | |
| Net Income | -- | -9.00% | 233.93% | 255.17% | |
| EBIT | -- | 23.81% | 154.09% | 413.31% | |
| EBITDA | -- | 22.62% | 121.79% | 545.29% | |
| EPS Basic | -- | -7.39% | 233.08% | 256.52% | |
| Normalized Basic EPS | -- | 29.68% | 156.10% | 434.38% | |
| EPS Diluted | -- | -7.39% | 233.08% | 256.48% | |
| Normalized Diluted EPS | -- | 29.68% | 156.10% | 434.38% | |
| Average Basic Shares Outstanding | -- | -1.51% | -0.99% | -0.50% | |
| Average Diluted Shares Outstanding | -- | -1.51% | -0.99% | -0.50% | |
| Dividend Per Share | -- | 2.57% | 3.35% | 3.35% | |
| Payout Ratio | -- | -- | -- | -- | |